PATENT CLAIM ANALYSIS

Application Number: 15918308
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "502000"]

Abstract:
The present invention discloses a novel form of ferric organic compounds, including a form of ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. The ferric organic compounds of the present invention can be delivered effectively by oral route with better delivery to treat patients suffering from hyperphosphatemia, metabolic acidosis and other disorders responsive to ferric organic compound therapy.

Claim (Index 82):
A method of treating metabolic acidosis, comprising:\n administering a therapeutically effective amount of an orally administrable form of ferric citrate to a subject, wherein the orally administrable form is prepared from a form of ferric citrate having a BET active surface area greater than 16 sq. m/g.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.44231
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15143987', '14011357', '14011325', '11206981', '14502774']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7659943674586286
- 35 USC 102 Novelty (BERT): 0.5230148417354549
- Combined Prediction Score: 0.7416964148863112
- Mean Citation Score: 329.0986420000001
- Max Citation Score: 344.35843
- Similarity Product: 315.86204381229766

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test